|
🐜
|
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
28 auth.
R. Kootte,
E. Levin,
J. Salojärvi,
L. Smits,
Annick V. Hartstra,
S. D. Udayappan,
Gerben D. A. Hermes,
K. Bouter,
Annefleur M. Koopen,
J. Holst,
F. Knop,
E. Blaak,
J. Zhao,
H. Smidt,
A. Harms,
...
Thomas Hankemeijer,
J. Bergman,
H. Romijn,
F. Schaap,
S. O. Olde Damink,
M. Ackermans,
G. Dallinga-Thie,
E. Zoetendal,
W. D. de Vos,
M. Serlie,
E. Stroes,
A. Groen,
M. Nieuwdorp
|
9 |
2017 |
9
🐜
|
|
🦁
|
Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
28 auth.
Annefleur M. Koopen,
J. Witjes,
Koen Wortelboer,
S. Majait,
A. Prodan,
E. Levin,
H. Herrema,
M. Winkelmeijer,
S. Aalvink,
J. Bergman,
Stephan Havik,
B. Hartmann,
H. Levels,
Per-Olof Bergh,
Jamie van Son,
...
Manon Balvers,
D. Bastos,
E. Stroes,
A. Groen,
Marcus Henricsson,
E. M. Kemper,
J. Holst,
Christopher M Strauch,
S. Hazen,
F. Bäckhed,
W. D. de Vos,
M. Nieuwdorp,
Elena Rampanelli
|
5 |
2021 |
5
🦁
|
|
🦁
|
Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome
18 auth.
Annefleur M. Koopen,
Eduardo L Almeida,
Ilias Attaye,
J. Witjes,
Elena Rampanelli,
S. Majait,
Marleen Kemper,
J. Levels,
A. Schimmel,
H. Herrema,
...
Torsten P. M. Scheithauer,
Werner Frei,
L. Dragsted,
B. Hartmann,
J. Holst,
P. O’Toole,
A. Groen,
M. Nieuwdorp
|
5 |
2021 |
5
🦁
|
|
🦁
|
Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk
Annefleur M. Koopen,
A. Groen,
M. Nieuwdorp
|
5 |
2016 |
5
🦁
|
|
🐬
|
From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
Koen Wortelboer,
Annefleur M. Koopen,
H. Herrema,
W. D. de Vos,
M. Nieuwdorp,
E. Kemper
|
3 |
2022 |
3
🐬
|
|
🐜
|
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects
18 auth.
G. Bakker,
J. Schnitzler,
S. Bekkering,
Nicolien C de Clercq,
Annefleur M. Koopen,
Annick V. Hartstra,
E. Meessen,
Torsten P. M. Scheithauer,
M. Winkelmeijer,
G. Dallinga-Thie,
...
Patrice D Cani,
E. Kemper,
M. Soeters,
J. Kroon,
A. Groen,
D. V. van Raalte,
H. Herrema,
M. Nieuwdorp
|
3 |
2019 |
3
🐜
|
|
🦁
|
Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
11 auth.
Annefleur M. Koopen,
Nicolien C de Clercq,
Moritz V. Warmbrunn,
H. Herrema,
M. Davids,
P. D. de Groot,
...
R. Kootte,
K. Bouter,
M. Nieuwdorp,
A. Groen,
A. Prodan
|
3 |
2020 |
3
🦁
|
|
🐜
|
Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk
15 auth.
Moritz V. Warmbrunn,
Annefleur M. Koopen,
Nicolien C de Clercq,
P. D. de Groot,
R. Kootte,
K. Bouter,
K. T. ter Horst,
Annick V. Hartstra,
M. Serlie,
M. Ackermans,
...
M. Soeters,
D. V. van Raalte,
M. Davids,
M. Nieuwdorp,
A. Groen
|
2 |
2021 |
2
🐜
|
|
🐜
|
Iloprost infusion prevents the insulin‐induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients
10 auth.
Anna L. Emanuel,
Nicolien C de Clercq,
Annefleur M. Koopen,
Erik M van Poelgeest,
M. Serlie,
D. V. van Raalte,
...
M. Kramer,
M. Nieuwdorp,
E. Eringa,
E. Serné
|
2 |
2018 |
2
🐜
|
